Delivery Order SPE2DB22D1002-SPE2DB25FLCA6

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,103.47, is for the delivery of 4567268097 ! CEFDINIR 300 MG CAPSULE 60S. It is a firm fixed-price delivery order with a completion date of February 14, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CEFDINIR 250MG/5ML 1S, a pharmaceutical product. The contract has a ceiling value of $1,336.41 and is a firm fixed-price delivery order with a completion date of May 15, 2025. The contract is not set aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.66, is for the delivery of CEFDINIR 300 MG CAPSULE 60S. It is a firm fixed-price delivery order contract with a completion date of March 31, 2025. The contract was awarded on March 28, 2025 and does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a $7,804 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,492,739 units of the pharmaceutical drug Cefdinir 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to provide CEFDINIR 125 MG/5 ML SUSP 100ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. The order, valued at $3,274.91, has an ultimate completion date of March 26, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor on an...
This federal contract award, valued at $8,009.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,033,991 units of the antibiotic medication Cefdinir 300 mg capsules. The contract has a firm fixed price and an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,369.24 firm fixed price delivery order is for the supply of 4563301233 - CEFDINIR 300 MG CAPSULE 60S to support military treatment programs and facilities. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a history of providing...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $522 to Amerisourcebergen Drug Corporation for 4561741005 CEFDINIR 300 MG CAPSULE 60S. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 9, 2023 in support of the Defense Logistics Agency's medical supply chain responsibilities. No subcontractors or set aside designations were indicated. The delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $16,136.40 firm fixed price delivery order is for the supply of 4,565,564,946 units of the pharmaceutical drug Cefdinir 300 mg capsules. The award is not associated with a set-aside program and has an ultimate completion date of August 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,732.47, is a delivery order for the pharmaceutical product CEFDINIR 250 MG/5 ML SUSP 60ML. The contract has an ultimate completion date of November 18, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FLCA6
    Delivery Order

This is a $1,633.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFDINIR 300 MG CAPSULE 60S, a pharmaceutical product, with a performance period through May 13, 2025. This delivery order is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 12:59 AM